Matches in Wikidata for { <http://www.wikidata.org/entity/Q37027759> ?p ?o ?g. }
- Q37027759 description "article científic" @default.
- Q37027759 description "article scientifique" @default.
- Q37027759 description "articolo scientifico" @default.
- Q37027759 description "artigo científico" @default.
- Q37027759 description "artículu científicu espublizáu en 2012" @default.
- Q37027759 description "bilimsel makale" @default.
- Q37027759 description "scientific article published on 27 February 2012" @default.
- Q37027759 description "vedecký článok" @default.
- Q37027759 description "vetenskaplig artikel" @default.
- Q37027759 description "videnskabelig artikel" @default.
- Q37027759 description "vědecký článek" @default.
- Q37027759 description "wetenschappelijk artikel" @default.
- Q37027759 description "wissenschaftlicher Artikel" @default.
- Q37027759 description "наукова стаття, опублікована в лютому 2012" @default.
- Q37027759 description "научни чланак" @default.
- Q37027759 description "مقالة علمية نشرت في 27 فبراير 2012" @default.
- Q37027759 name "Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure" @default.
- Q37027759 name "Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure" @default.
- Q37027759 name "Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure." @default.
- Q37027759 type Item @default.
- Q37027759 label "Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure" @default.
- Q37027759 label "Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure" @default.
- Q37027759 label "Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure." @default.
- Q37027759 prefLabel "Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure" @default.
- Q37027759 prefLabel "Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure" @default.
- Q37027759 prefLabel "Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure." @default.
- Q37027759 P1433 Q37027759-D44D034F-61D7-45F3-B639-32BBE36BC072 @default.
- Q37027759 P1476 Q37027759-DA1B40E6-A5D8-48BB-999D-AF4C834B7307 @default.
- Q37027759 P2093 Q37027759-4BDAC60B-92F8-40EF-9010-53FA2BBCD57F @default.
- Q37027759 P2093 Q37027759-E3D67BA2-21F7-4399-AD67-B136F9D51970 @default.
- Q37027759 P2093 Q37027759-F332BF50-B006-4F9C-9782-D50A4C629744 @default.
- Q37027759 P2860 Q37027759-077F0758-3D6C-45FD-A41F-5122E69FD34F @default.
- Q37027759 P2860 Q37027759-0A020D92-5356-47F7-B643-EDA13A2052CA @default.
- Q37027759 P2860 Q37027759-18FBCD2A-ACED-4AB4-9970-14DE81CF8982 @default.
- Q37027759 P2860 Q37027759-1E471D4B-3EFA-4426-AC90-61C5ACDA5C5A @default.
- Q37027759 P2860 Q37027759-245AB318-0DB4-444B-B743-1D42514F28B3 @default.
- Q37027759 P2860 Q37027759-2F621371-B47D-461C-BDFC-44D2F38D96E2 @default.
- Q37027759 P2860 Q37027759-31A627E7-25FE-4EB5-A9CF-DEE050A0B339 @default.
- Q37027759 P2860 Q37027759-3B9E015C-C957-459B-A5A1-1110E4F0D484 @default.
- Q37027759 P2860 Q37027759-423FC369-FF5E-4F96-8D36-49CEC32E4473 @default.
- Q37027759 P2860 Q37027759-46C134EE-805C-4B90-8223-6960791B00B9 @default.
- Q37027759 P2860 Q37027759-57BFCB6D-527B-4EEF-BF97-BD2253A9DC1E @default.
- Q37027759 P2860 Q37027759-58434739-F331-4FFF-AF16-E18FD2A0A067 @default.
- Q37027759 P2860 Q37027759-605FCA4F-1356-4690-B161-B595465AAA21 @default.
- Q37027759 P2860 Q37027759-61C62161-AB6E-494B-9A34-95DB8497D1B3 @default.
- Q37027759 P2860 Q37027759-65F25E9F-3FE2-4223-BDB5-7C1FDD3D9964 @default.
- Q37027759 P2860 Q37027759-6DCB3574-B81A-419A-8C51-763AE4D7E5EB @default.
- Q37027759 P2860 Q37027759-7758882C-6770-413A-A620-930541D3FACD @default.
- Q37027759 P2860 Q37027759-81B0B7A7-1E08-483E-9EA5-145789B986DE @default.
- Q37027759 P2860 Q37027759-901A29B5-7AEB-4B94-AB86-BAF4899DB166 @default.
- Q37027759 P2860 Q37027759-93F4E8FF-98DC-4457-9E6F-BEDCBD9E1C98 @default.
- Q37027759 P2860 Q37027759-A3EF4DDC-1F6A-4310-8497-FF059A8A582D @default.
- Q37027759 P2860 Q37027759-B27B6768-7F4F-487E-81D1-BEA9694F6B88 @default.
- Q37027759 P2860 Q37027759-D2C1D9EB-1C64-455C-B531-D9E2E5C60C9F @default.
- Q37027759 P2860 Q37027759-FDF07381-37BB-4385-B730-FBE5FE91EAB2 @default.
- Q37027759 P2860 Q37027759-FE740DE6-2FA1-4776-816B-F1697CF979A4 @default.
- Q37027759 P304 Q37027759-010CA730-12E9-41D4-A0F7-EDA97CB92AC5 @default.
- Q37027759 P31 Q37027759-D6B34295-D5F9-4630-92DC-3D82FAEB0403 @default.
- Q37027759 P356 Q37027759-CE984644-88ED-4051-8069-7310E3B731C6 @default.
- Q37027759 P407 Q37027759-E4075D74-6947-4181-8918-B3A5F46A3385 @default.
- Q37027759 P433 Q37027759-6B3C5AF0-041E-4FCB-8E7F-04E32678237A @default.
- Q37027759 P478 Q37027759-B43B5FAB-E0CE-487B-9A6E-A10CD9D91515 @default.
- Q37027759 P50 Q37027759-3DFEF720-8456-4F40-AAE7-008363BE0F22 @default.
- Q37027759 P50 Q37027759-53D6D0A5-7881-4275-AA07-B7319D6B19B1 @default.
- Q37027759 P50 Q37027759-6EF78535-CA27-43EC-8E08-E4E5EE1A185D @default.
- Q37027759 P50 Q37027759-7748A01E-6220-44C7-AB04-A3DA4B9FFFE0 @default.
- Q37027759 P50 Q37027759-8314412D-7D06-49CA-8810-E18048128169 @default.
- Q37027759 P50 Q37027759-8A4324D5-EAEF-4785-B563-4E89633BAD12 @default.
- Q37027759 P50 Q37027759-C953EC4F-BADF-4BDD-9CE4-2AFCCE4D9C8E @default.
- Q37027759 P50 Q37027759-D88C3C00-3828-454B-910F-9AEFE9BD2F5F @default.
- Q37027759 P50 Q37027759-FCF514D3-DD5D-42F6-9191-A411171C02D3 @default.
- Q37027759 P577 Q37027759-90820DC7-FAD3-4856-A93B-21F78BDC087B @default.
- Q37027759 P5875 Q37027759-89577FAB-7436-4B06-A6A2-97AAB3482B7A @default.
- Q37027759 P698 Q37027759-A806B3AB-ADA6-4878-A0AB-1218BF2C827C @default.
- Q37027759 P921 Q37027759-601AE522-11E1-4860-AD2E-DF60475F7CBC @default.
- Q37027759 P921 Q37027759-6BF36C83-F772-4B1B-9E59-8F3A5C4D20DA @default.
- Q37027759 P921 Q37027759-7EC0F0B3-8E77-4A20-958D-BC9594C4D8E8 @default.
- Q37027759 P921 Q37027759-8F1CDA95-9BA7-496A-8E77-D2D6FA2C4D4C @default.
- Q37027759 P921 Q37027759-B9353844-9A10-4F3D-B298-2C53AE209D77 @default.
- Q37027759 P921 Q37027759-C42754D0-92E0-4925-9DC8-34FEEDD52717 @default.
- Q37027759 P932 Q37027759-98037C62-6EE8-49F3-9C94-1018B99314A6 @default.
- Q37027759 P356 BLOOD-2011-11-390120 @default.
- Q37027759 P698 22371878 @default.
- Q37027759 P1433 Q885070 @default.
- Q37027759 P1476 "Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure" @default.
- Q37027759 P2093 "Dong-Wook Kim" @default.
- Q37027759 P2093 "Eric Leip" @default.
- Q37027759 P2093 "H Jean Khoury" @default.
- Q37027759 P2860 Q28246204 @default.
- Q37027759 P2860 Q33379225 @default.
- Q37027759 P2860 Q33379934 @default.
- Q37027759 P2860 Q33394812 @default.
- Q37027759 P2860 Q33686190 @default.
- Q37027759 P2860 Q34183674 @default.
- Q37027759 P2860 Q34210528 @default.
- Q37027759 P2860 Q34567629 @default.
- Q37027759 P2860 Q34582817 @default.
- Q37027759 P2860 Q34622576 @default.
- Q37027759 P2860 Q34808070 @default.
- Q37027759 P2860 Q35548766 @default.